Literature DB >> 24101666

Potential therapeutic role of phosphodiesterase type 5 inhibition in hypertension and chronic kidney disease.

Kayleigh E Brown1, Neeraj Dhaun, Jane Goddard, David J Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24101666     DOI： 10.1161/HYPERTENSIONAHA.113.01774

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  17 in total

Review 1.  Aging, arterial stiffness, and hypertension.

Authors:  Zhongjie Sun
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Sildenafil improves renal function in patients with pulmonary arterial hypertension.

Authors:  David J Webb; Jean-Luc Vachiery; Lie-Ju Hwang; Julie O Maurey
Journal:  Br J Clin Pharmacol       Date:  2015-05-19       Impact factor: 4.335

3.  Multiple drug-intolerant hypertension: a case series utilising a novel-treatment algorithm.

Authors:  Manish Saxena; Sotiris Antoniou; Nadya Hamedi; Paul Robinson; Harjit Singh; Omar Mukhtar; Vikas Kapil; Melvin D Lobo
Journal:  Br J Gen Pract       Date:  2016-04       Impact factor: 5.386

Review 4.  Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension.

Authors:  Allen W Cowley; Michiaki Abe; Takefumi Mori; Paul M O'Connor; Yusuke Ohsaki; Nadezhda N Zheleznova
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-29

Review 5.  Genetics of resistant hypertension: a novel pharmacogenomics phenotype.

Authors:  Nihal El Rouby; Rhonda M Cooper-DeHoff
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 6.  DNA Damage: A Main Determinant of Vascular Aging.

Authors:  Paula K Bautista-Niño; Eliana Portilla-Fernandez; Douglas E Vaughan; A H Jan Danser; Anton J M Roks
Journal:  Int J Mol Sci       Date:  2016-05-18       Impact factor: 5.923

7.  Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7.

Authors:  Riccardo Pofi; Daniela Fiore; Rita De Gaetano; Giuseppe Panio; Daniele Gianfrilli; Carlotta Pozza; Federica Barbagallo; Yang Kevin Xiang; Konstantinos Giannakakis; Susanna Morano; Andrea Lenzi; Fabio Naro; Andrea M Isidori; Mary Anna Venneri
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

Review 8.  Nitric oxide signalling in kidney regulation and cardiometabolic health.

Authors:  Mattias Carlström
Journal:  Nat Rev Nephrol       Date:  2021-06-01       Impact factor: 28.314

Review 9.  Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension.

Authors:  Evanthia Mergia; Johannes Stegbauer
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

10.  Management of Hypertensive Patients With Multiple Drug Intolerances: A Single-Center Experience of a Novel Treatment Algorithm.

Authors:  Sotiris Antoniou; Manish Saxena; Nadya Hamedi; Catherine de Cates; Sakib Moghul; Satnam Lidder; Vikas Kapil; Melvin D Lobo
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-26       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.